Citigroup appointed Vicore Pharma Depositary Bank
Analysis based on 8 articles · First reported Jul 06, 2026 · Last updated Jul 06, 2026
This appointment is a minor positive for both Citigroup and Vicore Pharma Holding. Citigroup expands its depositary receipt services, while Vicore Pharma Holding gains enhanced access to global capital markets through its ADR program.
Citigroup, through its Citi Issuer Services and Citigroup — Citibank N.A. units, has been appointed by Vicore Pharma Holding as the Depositary Bank for its sponsored Level 2 American Depositary Receipt (ADR) program. This appointment will allow Vicore Pharma Holding's ADRs to trade on the Nasdaq Capital Market under the symbol 'VCRE', with each ADS representing ten ordinary shares. Vicore Pharma Holding's underlying ordinary shares are already listed on the Nasdaq Stockholm Stock Exchange. Dirk Jones, Head of Issuer Services at Citigroup, emphasized Citigroup's commitment to supporting Vicore Pharma Holding with high-quality ADR solutions and facilitating access to global capital markets.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard